BioCentury
ARTICLE | Company News

Seattle Genetics management update

October 7, 2013 7:00 AM UTC

Seattle Genetics Inc. (NASDAQ:SGEN), Bothell, Wash. Business: Cancer, Autoimmune Promoted: Jonathan Drachman to EVP of R&D and CMO from SVP of research and translational medicine; and Eric Sievers to ...